Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H32NO.Cl |
Molecular Weight | 337.927 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].C[N+]3(CCC(O)(C1CCCCC1)C2=CC=CC=C2)CCCC3
InChI
InChIKey=PISKUTGWQHZKIK-UHFFFAOYSA-M
InChI=1S/C20H32NO.ClH/c1-21(15-8-9-16-21)17-14-20(22,18-10-4-2-5-11-18)19-12-6-3-7-13-19;/h2,4-5,10-11,19,22H,3,6-9,12-17H2,1H3;1H/q+1;/p-1
Tricyclamol is a quaternary ammonium compound, which is a crystalline odorless substance, readily soluble in water. It may be given by mouth or by subcutaneous injection. Tricyclamol was used for its spasmolytic action on smooth muscle. In animals it inhibits the spasmogenic effects of acetylcholine (ACh), carbachol, pilocarpine and barium chloride. In relaxing ACh-induced spasm of isolated rabbit ileum the activities of the dextro and laevo isomers of tricyclamol were approximately 0.006 and 2 times that of atropine sulphate respectively. Further, in inhibiting the stretch reflex of isolated guinea-pig ileum the laevo isomer was much more active than the dextro and about twice as potent as the racemate. Tricyclamol blocks the superior cervical ganglion. Tricyclamol chloride has a marked effect in reducing the motility of the stomach and duodenum, and to a far greater extent than the results produced by hyoscyamine. This action may be of value in controlling the pain of peptic ulceration, since it is likely that the pain, at least in part, is due to spasm.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism. | 1966 Jun |
|
Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders. | 1970 Dec |
|
Central role of solar information flow in pregenetic evolution. | 1971 Jun |
|
Ethopropazine and benztropine in neuroleptic-induced parkinsonism. | 1979 Mar |
|
Neuroleptic malignant syndrome. | 1983 Jun 18 |
|
Bilateral ulnar nerve paralysis: an unreported complication of drug-induced extrapyramidal rigidity. | 1997 Jun |
|
Anti-nicotinic properties of anticholinergic antiparkinson drugs. | 1998 Nov |
|
An extrapyramidal reaction to ondansetron. | 1998 Oct |
|
Effects of advanced candidate anticonvulsants under two rodent models of 'counting'. | 2001 Dec |
|
Effects of procyclidine on prepulse inhibition of the acoustic startle response in healthy human volunteers. | 2001 Mar |
|
Neuroleptics and family history of Parkinson diseases: case report. | 2001 May |
|
Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care. | 2002 Dec |
|
Effects of procyclidine on eye movements in schizophrenia. | 2003 Dec |
|
Screening and semi-quantitative analysis of post mortem blood for basic drugs using gas chromatography/ion trap mass spectrometry. | 2004 Dec 25 |
|
Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats. | 2004 Nov 28 |
|
Drug-human serum albumin binding studied by capillary electrophoresis with electrochemiluminescence detection. | 2004 Oct |
|
Self-reported parkinsonian symptoms in the EPIC-Norfolk cohort. | 2005 Aug 24 |
|
Soman-induced convulsions in rats terminated with pharmacological agents after 45 min: neuropathology and cognitive performance. | 2005 Jan |
|
Primary care use of antipsychotic drugs: an audit and intervention study. | 2005 Nov 29 |
|
Low dose quetiapine induced galactorrhoea: a case report. | 2007 Jul 24 |
|
Clozapine and co-prescribed psychotropics: a short report. | 2008 Apr 25 |
|
Anticonvulsant efficacy of drugs with cholinergic and/or glutamatergic antagonism microinfused into area tempestas of rats exposed to soman. | 2008 Feb |
|
Antiparkinson drugs used as prophylactics for nerve agents: studies of cognitive side effects in rats. | 2008 Jun |
|
Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II. | 2009 Dec |
|
Fatalities associated with clozapine-related constipation and bowel obstruction: a literature review and two case reports. | 2009 Jul-Aug |
|
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | 2010 Dec |
|
The use of organotypic hippocampal slice cultures to evaluate protection by non-competitive NMDA receptor antagonists against excitotoxicity. | 2010 Mar |
|
Structured relaxation in the treatment of akathisia: case series. | 2010 May 25 |
|
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. | 2011 Jul 14 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29701
Created by
admin on Fri Dec 15 17:53:58 GMT 2023 , Edited by admin on Fri Dec 15 17:53:58 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID10959111
Created by
admin on Fri Dec 15 17:53:58 GMT 2023 , Edited by admin on Fri Dec 15 17:53:58 GMT 2023
|
PRIMARY | |||
|
QYH21J350Z
Created by
admin on Fri Dec 15 17:53:58 GMT 2023 , Edited by admin on Fri Dec 15 17:53:58 GMT 2023
|
PRIMARY | |||
|
100000077720
Created by
admin on Fri Dec 15 17:53:58 GMT 2023 , Edited by admin on Fri Dec 15 17:53:58 GMT 2023
|
PRIMARY | |||
|
72169
Created by
admin on Fri Dec 15 17:53:58 GMT 2023 , Edited by admin on Fri Dec 15 17:53:58 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110635
Created by
admin on Fri Dec 15 17:53:58 GMT 2023 , Edited by admin on Fri Dec 15 17:53:58 GMT 2023
|
PRIMARY | |||
|
3818-88-0
Created by
admin on Fri Dec 15 17:53:58 GMT 2023 , Edited by admin on Fri Dec 15 17:53:58 GMT 2023
|
PRIMARY | |||
|
SUB11279MIG
Created by
admin on Fri Dec 15 17:53:58 GMT 2023 , Edited by admin on Fri Dec 15 17:53:58 GMT 2023
|
PRIMARY | |||
|
C152739
Created by
admin on Fri Dec 15 17:53:58 GMT 2023 , Edited by admin on Fri Dec 15 17:53:58 GMT 2023
|
PRIMARY | |||
|
2736
Created by
admin on Fri Dec 15 17:53:58 GMT 2023 , Edited by admin on Fri Dec 15 17:53:58 GMT 2023
|
PRIMARY | |||
|
458
Created by
admin on Fri Dec 15 17:53:58 GMT 2023 , Edited by admin on Fri Dec 15 17:53:58 GMT 2023
|
PRIMARY | |||
|
223-311-5
Created by
admin on Fri Dec 15 17:53:58 GMT 2023 , Edited by admin on Fri Dec 15 17:53:58 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD